0001237899-12-000052.txt : 20120502
0001237899-12-000052.hdr.sgml : 20120502
20120502115751
ACCESSION NUMBER: 0001237899-12-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120501
FILED AS OF DATE: 20120502
DATE AS OF CHANGE: 20120502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 12803560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0305
4
2012-05-01
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
EVP CSO President Regeneron Re
Common Stock
2012-05-01
4
S
0
100.0
133.95
D
866106.0
D
Common Stock
2012-05-01
4
S
0
20120.0
134.54
D
845986.0
D
Common Stock
2012-05-01
4
S
0
12945.0
135.29
D
833041.0
D
Common Stock
5534.0
I
By 401(k) Plan
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 20,120 shares of Company stock on May 1, 2012 at prices ranging from $134.01 to $134.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price.
Represents volume-weighted average price of sales of 12,945 shares of Company stock on May 1, 2012 at prices ranging from $135.01 to $135.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2012 at each separate price.
/s/**George D. Yancopoulos
2012-05-02